Cited by 821Cardiac electrophysiology and arrhythmiasAcute Myocardial Infarction ResearchCardiac pacing and defibrillation studies

The DOI matches its Crossref record, with a small difference in title or year; 116 of the 116 references it cites were found in a registry or an index.

Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

Open access

Drew, Barbara J., Ackerman, Michael J., Funk, Marjorie, Gibler, W. Brian, Kligfield, Paul, Menon, Venu, Philippides, George J., Roden, Dan M., Zareba, Wojciech·2010·Circulation

DOI 10.1161/circulationaha.109.192704PMC PMC3056123

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.109.192704

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Self-citation
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Self-citation
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353
Approaches to Sudden Death from Coronary Heart Disease
Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Flagged first, then by citations

Show all 115 references

Research works printed but not linked: 8

Dessertenne F. La tachycardie ventriculaire á deux foyers opposes variables. Arch Mal Coeur Vaiss. 1966; 59: 263–272.
10.1161/circ.105.10.1247 · DOI
10.1161/circ.96.12.4392 · DOI
10.1161/circ.97.5.493 · DOI
10.1161/res.55.3.6088114 · DOI
10.1001/jama.1993.03510210076031 · DOI
10.1161/circ.96.7.2149 · DOI
10.1097/01.AACN.0000284429.45534.4a · DOI

Sorted by citations

Items 101–200 of 821

Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction
Wei, X., Zhang, Z., Wei, J., & Luo, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1248655 · Cited by 64
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
KONES, R. J. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s11100 · Cited by 64
QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications
Fernandes, F. E. M., da Silva, E. P., Martins, R. R., & Oliveira, A. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199028 · Cited by 62
Influence of heart rate correction formulas on QTc interval stability
Andršová, I., Hnatkova, K., Šišáková, M., Toman, O., Smetana, P., Huster, K. M., Barthel, P., Novotný, T., Schmidt, G. P., & Malík, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93774-9 · Cited by 61
R-From-T as a Common Mechanism of Arrhythmia Initiation in Long QT Syndromes
Liu, M. B., Vandersickel, N., Panfilov, A. V., & Qu, Z. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007571 · Cited by 61
Prevalence and determinants of QT interval prolongation in medical inpatients
Pasquier, M., Pantet, O., Hügli, O., Pruvot, E. J., Buclin, T., Waeber, G., & Aujesky, D. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02447.x · Cited by 59
Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval
Ghouse, J., Have, C. T., Weeke, P. E., Nielsen, J. B., Ahlberg, G., Balslev‐Harder, M., Appel, E. V. R., Skaaby, T., Olesen, S., Grarup, N., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv297 · Cited by 58
Causes and Management of Drug-Induced Long Qt Syndrome
Ayad, R. F., Assar, M. D., Simpson, L., Garner, J. B., & SCHUSSLER, J. M. (2010) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2010.11928628 · Cited by 58
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
O’Connell, T. F., Bradley, C. J., Abbas, A. E., Williamson, B. D., Rusia, A., Tawney, A. M., Gaines, R., Schott, J., Dmitrienko, A. A., & Haines, D. E. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.016 · Cited by 58
Cardiac Alternans: From Bedside to Bench and Back
Qu, Z., & Weiss, J. N. (2023) · Circulation Research · doi:10.1161/circresaha.122.321668 · Cited by 57
Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest.
Sicouri, S., & Antzelevitch, C. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.29.2 · Cited by 58
Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine
Calcaterra, S. L., Martín, M., Bottner, R., Englander, H. L., Weinstein, Z., Weimer, M. B., Lambert, E., & Herzig, S. J. (2022) · Journal of Hospital Medicine · doi:10.1002/jhm.12893 · Cited by 58
Ambulatory ECG-Based T-Wave Alternans Monitoring for Risk Assessment and Guiding Medical Therapy: Mechanisms and Clinical Applications
Verrier, R. L., & Ikeda, T. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.07.002 · Cited by 55
Co-Prescription of QT-Interval Prolonging Drugs: An Analysis in a Large Cohort of Geriatric Patients
Schächtele, S., Tümena, T., Gaßmann, K., Fromm, M. F., & Maas, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155649 · Cited by 55
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse
Swank, K. A., Wu, E., Kortepeter, C. M., McAninch, J., & Levin, R. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.011 · Cited by 55
QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study
Guglielmetti, L., Tiberi, S., Burman, M., Kunst, H., Wejse, C. M., Togonidze, T., Bothamley, G. H., & Lange, C. G. (2018) · European Respiratory Journal · doi:10.1183/13993003.00537-2018 · Cited by 55
Measurement and Management of QT Interval Prolongation for General Physicians
Indraratna, P., Tardo, D. T., Delves, M., Szirt, R., & Ng, B. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05477-7 · Cited by 53
Bi-stable wave propagation and early afterdepolarization–mediated cardiac arrhythmias
Chang, M. G., Sato, D., de Lange, E., Lee, J.-H., Karagueuzian, H. S., Garfinkel, A., Weiss, J. N., & Qu, Z. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.014 · Cited by 53
Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU
Flannery, A. H., Adkins, D. A., & Cook, A. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001659 · Cited by 52
Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
Gagliano‐Jucá, T., Travison, T. G., Kantoff, P. W., Nguyen, P. L., Taplin, M., Kibel, A. S., Huang, G. T.-W., Bearup, R., Schram, H., Manley, R., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00039 · Cited by 52
Management of COVID-19 in people with epilepsy: drug considerations
Asadi‐Pooya, A. A., Attar, A., Moghadami, M., & Karimzadeh, I. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04549-5 · Cited by 51
Electrocardiographic Findings in Systemic Lupus Erythematosus: Data From an International Inception Cohort
Bourré‐Tessier, J., Urowitz, M. B., Clarke, A. E., Bernatsky, S., Krantz, M. J., Huynh, T. T., Joseph, L., Bélisle, P., Bae, S., Hanly, J. G., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22370 · Cited by 51
Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
Giudicessi, J. R., & Ackerman, M. J. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.13077 · Cited by 51
Self-citation
Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death
Woosley, R. L., Romero, K., Heise, C. W., Gallo, T., Tate, J., Woosley, R. D., & Ward, S. (2017) · Drug Safety · doi:10.1007/s40264-017-0519-0 · Cited by 51
Prolonged QT Interval Diagnosis Suppression by a Widely Used Computerized ECG Analysis System
Garg, A., & Lehmann, M. H. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.976803 · Cited by 51
Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Yates, C., & Manini, A. F. (2012) · Current Cardiology Reviews · doi:10.2174/157340312801784961 · Cited by 50
Mechanisms linking T‐wave alternans to spontaneous initiation of ventricular arrhythmias in rabbit models of long QT syndrome
Liu, W., Kim, T. Y., Huang, X., Liu, M. B., Koren, G., Choi, B., & Qu, Z. (2018) · The Journal of Physiology · doi:10.1113/jp275492 · Cited by 50
Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review
Muensterman, E. T., & Tisdale, J. E. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2146 · Cited by 50
Unnecessary arrhythmia monitoring and underutilization of ischemia and QT interval monitoring in current clinical practice: baseline results of the Practical Use of the Latest Standards for Electrocardiography trial
Funk, M., Winkler, C. G., May, J. L., Stephens, K., Fennie, K., Rose, L., Turkman, Y., & Drew, B. J. (2010) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2010.07.018 · Cited by 49
Self-citation
T-Wave Morphology Analysis in Congenital Long QT Syndrome Discriminates Patients From Healthy Individuals
Porta‐Sánchez, A., Spillane, D. R., Harris, L., Xue, J. Q., Dorsey, P., Care, M. E., Chauhan, V. S., Gollob, M. H., & SPEARS, D. A. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.10.013 · Cited by 49
QT prolongation predicts short-term mortality independent of comorbidity
Gibbs, C., Thalamus, J., Kristoffersen, D. T., Svendsen, M. V., Holla, Ø. L., Heldal, K., Haugaa, K. H., & Hysing, J. (2019) · EP Europace · doi:10.1093/europace/euz058 · Cited by 50
Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death
Simpson, T. F., Salazar, J. W., Vittinghoff, E., Probert, J., Iwahashi, A., Olgin, J. E., Ursell, P., Hart, A. P., Moffatt, E., & Tseng, Z. H. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0148 · Cited by 48
A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ‐PATH model
Vandael, E., Vandenberk, B., Vandenberghe, J., Van den Bosch, B., Willems, R., & Foulon, V. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13740 · Cited by 48
Synchronization of Early Afterdepolarizations and Arrhythmogenesis in Heterogeneous Cardiac Tissue Models
de Lange, E., Xie, Y., & Qu, Z. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.007 · Cited by 47
KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers
Koene, S., Spaans, E., Bortel, L. M. V., Lancker, G. V., Delafontaine, B., Badilini, F., Beyrath, J., & Smeitink, J. A. M. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0715-0 · Cited by 47
HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugs
Patanè, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.129 · Cited by 46
Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy
Roy, A. K., McCarthy, C., Kiernan, G., McGorrian, C., Keenan, E., Mahon, N., & Sweeney, B. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03767.x · Cited by 46
Hyperglycemia Is Associated With Corrected QT Prolongation and Mortality in Acutely Ill Patients
Pickham, D. M., Flowers, E., & Drew, B. J. (2013) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31827f174c · Cited by 46
Self-citation
Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease
Tsujimoto, T., Yamamoto‐Honda, R., Kajio, H., Kishimoto, M., Noto, H., Hachiya, R., Kimura, A., Kakei, M., & Noda, M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0640-9 · Cited by 45
Acquired long QT syndrome in chronic kidney disease patients
Liu, P., Wang, L., Han, D., Sun, C., Xue, X., & Li, G. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1707098 · Cited by 49
Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
Taha, H., Das, A., & Das, S. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s68396 · Cited by 49
Medical and physiological complications of exercise for individuals with an eating disorder: A narrative review
Quesnel, D. A., Cooper, M., Fernández-del-Valle, M., Reilly, A., & Calogero, R. M. (2023) · Journal of Eating Disorders · doi:10.1186/s40337-022-00685-9 · Cited by 51
Triazole antifungal drug interactions—practical considerations for excellent prescribing
Lewis, R. E., Niazi-Ali, S., McIvor, A., Kanj, S. S., Maertens, J. A., Bassetti, M., Levine, D. J., Groll, A. H., & Denning, D. W. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae103 · Cited by 43
Effect of Combined Fluoroquinolone and Azole Use on QT Prolongation in Hematology Patients
Zeuli, J. D., Wilson, J. W., & Estes, L. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00958-12 · Cited by 43
The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department
Cole, J. B., Lee, S. C., Martel, M. L., Smith, S. W., Biros, M. H., & Miner, J. R. (2020) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.4.47036 · Cited by 42
Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?
Mujtaba, S., Romero, J. E., & Taub, C. C. (2013) · Journal of Cardiovascular Disease Research · doi:10.1016/j.jcdr.2013.10.001 · Cited by 44
Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study
Danielsson, B. R. G., Collin, J., Nyman, A., Bergendal, A., Borg, N., State, M., Bergfeldt, L., & Fastbom, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034560 · Cited by 43
Drug‐induced long QT syndrome and fatal arrhythmias in the intensive care unit
Beitland, S., Platou, E. S., & Sunde, K. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12257 · Cited by 39
Impact of clinical decision support preventing the use of QT-prolonging medications for patients at risk for torsade de pointes
Sorita, A., Bos, J. M., Morlan, B. W., Tarrell, R. F., Ackerman, M. J., & Caraballo, P. J. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002896 · Cited by 41
Self-citation
Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
Lazzerini, P. E., Bertolozzi, I., Finizola, F., Acampa, M., Natale, M., Vanni, F., Fulceri, R., Gamberucci, A., Rossi, M., Giabbani, B., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00363 · Cited by 40
Understanding and managing cardiovascular outcomes in liver transplant recipients
Izzy, M. J., VanWagner, L. B., Lee, S. S., Altieri, M. H., Angirekula, M., & Watt, K. D. S. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000614 · Cited by 41
Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies
Jaiswal, A., & Goldbarg, S. H. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2013.12.021 · Cited by 40
Is QTc-Interval Prolongation an Inherent Feature of Eating Disorders? A Cohort Study
Krantz, M. J., Blalock, D. V., Tanganyika, K., Farasat, M., McBride, J., & Mehler, P. S. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.02.015 · Cited by 39
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data
Simon, S. T., Mandair, D., Tiwari, P., & Rosenberg, M. A. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248421995348 · Cited by 41
Tuberkulose im Erwachsenenalter
Schaberg, T., Brinkmann, F., Feiterna‐Sperling, C., Geerdes-Fenge, H. F., Hartmann, P., Häcker, B., Hauer, B., Haas, W., Heyckendorf, J., Lange, C. G., et al. (2022) · Pneumologie · doi:10.1055/a-1934-8303 · Cited by 39
Incidence and determinants of QT interval prolongation in COVID‐19 patients treated with hydroxychloroquine and azithromycin
Maraj, I., Hummel, J. P., Taoutel, R., Chamoun, R. S., Workman, V. K., Li, C., Tran, L. J., Delvecchio, A., Howes, C., & Akar, J. G. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14594 · Cited by 38
Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
Berger, F. A., van der Sijs, H., Becker, M. L., van Gelder, T., & van den Bemt, P. M. L. A. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01181-3 · Cited by 38
The influence of anesthesia on cardiac repolarization.
Owczuk, R., Wujtewicz, M., Zienciuk‐Krajka, A., Łasińska-Kowara, M., Piankowski, A., & Wujtewicz, M. (2012) · PubMed · Cited by 38
How many patients need QT interval monitoring in critical care units? Preliminary report of the QT in Practice study
Pickham, D. M., Helfenbein, E. D., Shinn, J. A., Chan, G. K., Funk, M., & Drew, B. J. (2010) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2010.05.016 · Cited by 38
Self-citation
Serum Calcium and Risk of Sudden Cardiac Arrest in the General Population
Yarmohammadi, H., Uy‐Evanado, A., Reinier, K., Rusinaru, C., Chugh, H. S., Jui, J., & Chugh, S. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.05.028 · Cited by 37
Management of serious cardiac adverse effects of antipsychotic medications
Stoner, S. C. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.11.246 · Cited by 37
Protease Inhibitor–Associated QT Interval Prolongation
Hunt, K., Hughes, C. A., & Hills-Nieminen, C. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q422 · Cited by 36
Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation
Niedrig, D., Mächler, S., Hoppe, L. K., Corti, N., Kovari, H., & Russmann, S. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2043-z · Cited by 36
QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics
Chandrasekhar, S. A., & Fradley, M. G. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0657-y · Cited by 39
QTc prolongation in COVID ‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis
Diaz‐Arocutipa, C., Brañez‐Condorena, A., & Hernández, A. V. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5234 · Cited by 38
Perioperative Torsade de Pointes
Johnston, J. D., Pal, S., & Nägele, P. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318290c380 · Cited by 36
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation
Bonow, R. O., Hernandez, A. F., & Turakhia, M. P. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1782 · Cited by 36
QTc monitoring in adults with medical and psychiatric comorbidities: Expert consensus from the Association of Medicine and Psychiatry
Xiong, G. L., Pinkhasov, A., Mangal, J. P., Huang, H., Rado, J. T., Gagliardi, J. P., DeMoss, D. S., Karol, D. E., Suo, S., Lang, M. C., et al. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110138 · Cited by 39
Long QT Syndrome and Perioperative Torsades de Pointes: What the Anesthesiologist Should Know
Niimi, N., Yuki, K., & Zaleski, K. L. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.12.011 · Cited by 35
Unanesthetized Rodents Demonstrate Insensitivity of QT Interval and Ventricular Refractory Period to Pacing Cycle Length
Mulla, W., Gillis, R., Murninkas, M., Klapper‐Goldstein, H., Gabay, H., Mor, M., Elyagon, S., Liel‐Cohen, N., Bernus, O., & Etzion, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00897 · Cited by 34
Cardiac Monitoring in the Emergency Department
Zègre‐Hemsey, J. K., Garvey, J. L., & Carey, M. G. (2016) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2016.04.009 · Cited by 34
An LQTS6 MiRP1 Mutation Suppresses Pacemaker Current and is Associated with Sinus Bradycardia
Nawathe, P. A., Kryukova, Y. N., Oren, R. V., Milanesi, R., Clancy, C. E., Lu, J. T., Moss, A. J., DiFrancesco, D., & Robinson, R. B. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12163 · Cited by 34
Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute
Vargas, H. M., Rossman, E. I., Wisialowski, T. A., Nichols, J. V., Pugsley, M. K., Roche, B. M., Gintant, G. A., Greiter‐Wilke, A., Kleiman, R., Valentin, J., et al. (2023) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2023.107265 · Cited by 33
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
Li, D., Chai, S., Wang, H., Dong, J., Qin, C., Du, D., Wang, Y., Du, Q., & Liu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1259611 · Cited by 34
Impact of Enteral Methadone on the Ability to Wean off Continuously Infused Opioids in Critically Ill, Mechanically Ventilated Adults: A Case-Control Study
Al‐Qadheeb, N. S., Roberts, R. J., Griffin, R. M., Garpestad, E., Ruthazer, R., & Devlin, J. W. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r132 · Cited by 33
Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose
Soroosh, D., Neamatshahi, M., Zarmehri, B., Nakhaee, S., & Mehrpour, O. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0196-3 · Cited by 33
Effects of antidepressants on QT interval in people with mental disorders
Aronow, W. S., & Shamliyan, T. (2020) · Archives of Medical Science · doi:10.5114/aoms.2019.86928 · Cited by 36
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
Baracaldo-Santamaría, D., Llinás-Caballero, K., Corso-Ramirez, J. M., Restrepo, C. M., Domínguez-Domínguez, C. A., Fonseca, D. J., & Calderón‐Ospina, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158090 · Cited by 32
Absence of an association between anti-Ro antibodies and prolonged QTc interval in systemic sclerosis: A multicenter study of 689 patients
Massie, C., Hudson, M., Tatibouet, S., Steele, R. J., Huynh, T. T., Fritzler, M. J., Baron, M. G., & Pineau, C. A. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.07.001 · Cited by 33
Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist
Uvelin, A., Pejaković, J., & Mijatović, V. (2017) · Journal of Anesthesia · doi:10.1007/s00540-017-2314-6 · Cited by 36
Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
K.‐W., T., Chow, K.-M., Choy, A. S. M., Kwan, B. C., Szeto, C., & Li, P. K.-T. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu098 · Cited by 32
Prevalence of the risk factors for QT prolongation and associated drug–drug interactions in a cohort of medical inpatients
Khan, Q., Ismail, M., Haider, I., & Ali, Z. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.016 · Cited by 32
Effect of Chronic Domperidone Use on QT Interval
Field, J. S., Wasilewski, M. A., Bhuta, R. V., Malik, Z. A., Cooper, J. M., Parkman, H. P., & Schey, R. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001183 · Cited by 32
Incidence of drug-induced torsades de pointes with intravenous amiodarone
Shenthar, J., Rachaiah, J. M., Pillai, V. V., Chakali, S. S., Balasubramanian, V., & Nanjappa, M. C. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.05.024 · Cited by 32
Mechanisms of drug-induced proarrhythmia in clinical practice
Konstantopoulou, A. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i6.175 · Cited by 30
Sevoflurane postconditioning attenuates reperfusion-induced ventricular arrhythmias in isolated rat hearts exposed to ischemia/reperfusion injury
Gong, J., Yao, Y.-T., Fang, N., & Li, L. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1447-9 · Cited by 31
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R)
Wang, F., Liu, J., Li, H., Liang, B., Graff, C., Yang, Y., Christiansen, M., Olesen, S., Zhang, L., & Kanters, J. K. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.022 · Cited by 31
QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors
Berger, F. A., Monadian, N., de Groot, N. M. S., Santbergen, B., van der Sijs, H., Becker, M. L., Broers, A. E. C., van Gelder, T., & van den Bemt, P. M. L. A. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13457 · Cited by 32
Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms
Kline-Krammes, S., Jacobs, T., Clark, J. M., & Lutes, R. E. (2016) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000757 · Cited by 31
The Role of CAV3 in Long–QT Syndrome
Hedley, P. L., Kanters, J. K., Dembić, M., Jespersen, T., Skibsbye, L., Aidt, F., Eschen, O., Graff, C., Behr, E. R., Schlamowitz, S., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000137 · Cited by 31
Prolonged QT Interval in Cirrhosis: Twisting Time?
Lee, W., Vandenberk, B., Raj, S. R., & Lee, S. S. (2022) · Gut and Liver · doi:10.5009/gnl210537 · Cited by 32
Emergency department approach to QTc prolongation
Pourmand, A., Mazer-Amirshahi, M. E., Chistov, S., Sabha, Y., Vukomanovic, D., & Almulhim, M. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.08.044 · Cited by 30
Risk of QTc Interval Prolongation Associated With Circulating Anti‐Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study
Lazzerini, P. E., Cevenini, G., Qu, Y. S., Fabris, F., El‐Sherif, N., Acampa, M., Cartocci, A., Pasini, F. L., Capecchi, P. L., Boutjdir, M., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018735 · Cited by 30
R-on-T and the initiation of reentry revisited: Integrating old and new concepts
Qu, Z., Liu, M. B., Olcese, R., Karagueuzian, H. S., Garfinkel, A., Chen, P., & Weiss, J. N. (2022) · Heart Rhythm · doi:10.1016/j.hrthm.2022.03.1224 · Cited by 30
Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening
Tisdale, J. E., Jaynes, H. A., Overholser, B. R., Sowinski, K. M., Flockhart, D. A., & Kovacs, R. J. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.02.015 · Cited by 30
Incidence of Torsade de Pointes in a tertiary hospital population
Vandael, E., Vandenberk, B., Vandenberghe, J. U., Pincé, H., Willems, R., & Foulon, V. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.072 · Cited by 30
Magnesium in health and disease
Kisters, K., & Gröber, U. (2013) · Plant and Soil · doi:10.1007/s11104-013-1709-x · Cited by 29
Early drug development: assessment of proarrhythmic risk and cardiovascular safety
Lester, R. M., & Olbertz, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1245142 · Cited by 29
Predictors of mortality in high-risk patients with QT prolongation in a community hospital
Gibbs, C., Thalamus, J., Heldal, K., Holla, Ø. L., Haugaa, K. H., & Hysing, J. (2017) · EP Europace · doi:10.1093/europace/eux286 · Cited by 29
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
Ngan, N. T. T., Mai, N. T. H., Tung, N. L. N., Lan, N. P. H., Tai, L. T. H., Phu, N. H., Chau, N. V. V., Binh, T. Q., Hung, L. Q., Beardsley, J., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15010.1 · Cited by 28

Authors: Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W.
ORCID: Ackerman, Michael J.
Funk, Marjorie
Menon, Venu
Philippides, George J.
Roden, Dan M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-03-02
Volume: 121
Issue: 8
Pages: 1047-1060
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.109.192704
PMC: PMC3056123
OpenAlex: W2082072065
Cited by: 821
References: 115
Citations by year: 2026: 32 · 2025: 37 · 2024: 49 · 2023: 41 · 2022: 48 · 2021: 81 · 2020: 90 · 2019: 69 · 2018: 51 · 2017: 62 · 2016: 46 · 2015: 39 · 2014: 43 · 2013: 43 · 2012: 38
FWCI: 28.78
Type: journal article
Language: en
Update notices: correction (2010-08-24)
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL081642)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: torsades de pointes, ventricular arrhythmia prevention, hospitalized patients, antiarrhythmic drugs, QT prolongation, drug-induced arrhythmia
MeSH terms: Electrocardiography, Heart Rate, Hospital Units, Humans, Monitoring, Physiologic, Risk Factors, United States, Torsades de Pointes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks